Federated Hermes
PYXS icon

Federated Hermes’s Pyxis Oncology PYXS Stock Holding History

Federated Hermes’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.64K Buy
3,181
+1,287
+68% +$1.94K ﹤0.01% 1897
2025
Q4 		$2.18K Buy
+1,894
New +$6.68K ﹤0.01% 1961
2025
Q2 		– Sell
-2,074
Closed -$2.03K – 2166
2025
Q1 		$2.03K Buy
+2,074
New +$2.77K ﹤0.01% 1948

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes's PYXS Position: Q1 2026 in Review

Federated Hermes increased its Pyxis Oncology (PYXS) stake by 68% in Q1 2026, buying an estimated $1.94K and bringing the position to 3,181 shares worth $4.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Federated Hermes first reported a position in PYXS in Q1 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Federated Hermes held 3,181 shares of Pyxis Oncology worth $4.64K as of Q1 2026.
  • Federated Hermes bought 1,287 Pyxis Oncology shares in Q1 2026, an estimated $1.94K.
  • Pyxis Oncology made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1897 holding.
  • Federated Hermes first reported a position in Pyxis Oncology in Q1 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.